The Curious Case Of FDA’s Approval Of Comirnaty

The FDA has long been criticized for its “revolving door” with Big Pharma where top executives move back and forth in top positions. The case of FDA approval of BioNTech’s Comirnaty gene therapy injection abandoned all traditional precedents in pushing it through: incomplete data and trials, insufficient control group and no review board. ⁃ TN EditorSTORY AT-A-GLANCE
August 23, 2021, the U.S. Food and Drug Administration granted full approval to the COVID-19 mRNA injectio